Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr-Jun;108(2):368504251335415.
doi: 10.1177/00368504251335415. Epub 2025 Apr 22.

A sporadic case of benign recurrent intrahepatic cholestasis in a growth-impaired young male

Affiliations
Case Reports

A sporadic case of benign recurrent intrahepatic cholestasis in a growth-impaired young male

Jiasheng Shao et al. Sci Prog. 2025 Apr-Jun.

Abstract

Benign recurrent intrahepatic cholestasis (BRIC) is a rare genetic liver disorder characterized by recurrent episodes of jaundice and severe pruritus without significant liver damage. Here, we present the case of a man in his early 20s, standing 143 cm tall, who has experienced recurrent jaundice and pruritus over an 18-year period. Laboratory investigations and liver biopsy examination indicated typical intrahepatic cholestasis with normal gamma-glutamyl transpeptidase levels, excluding viral, metabolic, and autoimmune causes. Further genetic analysis confirmed the diagnosis of BRIC with two compound heterozygous mutations in ATP8B1 gene on chromosome 18: NM_001374385.1: c.2081T > C p. (Ile694Thr) (rs541474497) in exon 18 and NC_000018.10 (NM_001374385.1): c.1631-2A > G in intron 15. To our knowledge, the latter has not been reported. Family lineage analysis and Sanger sequencing showed that these mutations were de novo rather than hereditary. Treatment with ursodeoxycholic acid and cholestyramine resulted in complete resolution of jaundice and pruritus, with normalization of serum bilirubin level after six months of therapy.

Keywords: Benign recurrent intrahepatic cholestasis; case report; growth impairment; jaundice; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

Conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
(a) and (b) The patient's body height of 143 cm, and yellow skin and sclera, respectively; (c) liver histology showed lobular structure remains intact (hematoxylin and eosin stain × 100), (d) bile plugs, mild hepatic plate swelling, diffuse hydropic degeneration of hepatocytes, and minor fibrous connective tissue were also observed (hematoxylin and eosin stain × 400).

Similar articles

References

    1. Summerskill WH, Walshe JM. Benign recurrent intrahepatic “obstructive” jaundice. Lancet 1959; 274: 686–690. - PubMed
    1. Luketic VA, Shiffman ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis 2004; 8: 133–149, vii. - PubMed
    1. Piazzolla M, Castellaneta N, Novelli A, et al. Nonsense variant of ATP8B1 gene in heterozygosis and benign recurrent intrahepatic cholestasis: a case report and review of literature. World J Hepatol 2020; 12: 64–71. - PMC - PubMed
    1. Hassan S, Hertel P. Overview of progressive familial intrahepatic cholestasis. Clin Liver Dis 2022; 26: 371–390. PMID: 35868680. - PubMed
    1. Folvik G, Hilde O, Helge GO. Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases. Scand J Gastroenterol 2012; 47: 482–488. - PubMed

Publication types

LinkOut - more resources